Clinical Trial Update: Docetaxel and Irinotecan in Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of docetaxel and irinotecan in gastric/stomach cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Stomach Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Menoufia University | Conditions: Stomach Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED